📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

An exploratory randomized-controlled trial of the efficacy of the Src-kinase inhibitor saracatinib as a novel analgesic for cancer-induced bone pain (2019)

First Author: Danson S

Attributed to: MICA: The role of Src in cancer-induced bone pain funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jbo.2019.100261

PubMed Identifier: 31667062

Publication URI: http://europepmc.org/abstract/MED/31667062

Type: Journal Article/Review

Parent Publication: Journal of Bone Oncology

ISSN: 2212-1366